药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levorphanol
Apalutamide
The metabolism of Lapatinib can be increased when combined with Apalutamide.
Levorphanol
Rifamycin
The metabolism of Lapatinib can be increased when combined with Rifamycin.
Levorphanol
Lumacaftor
The metabolism of Lapatinib can be increased when combined with Lumacaftor.
Levorphanol
Enzalutamide
The metabolism of Lapatinib can be increased when combined with Enzalutamide.
Levorphanol
Fosphenytoin
The metabolism of Lapatinib can be increased when combined with Fosphenytoin.
Levorphanol
Zopiclone
The metabolism of Zopiclone can be decreased when combined with Lapatinib.
Levorphanol
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Lapatinib.
Levorphanol
Retapamulin
The metabolism of Retapamulin can be decreased when combined with Lapatinib.
Levorphanol
Lonafarnib
The metabolism of Lapatinib can be decreased when combined with Lonafarnib.
Levorphanol
Lopinavir
The metabolism of Lopinavir can be decreased when combined with Lapatinib.
Levorphanol
Darunavir
The metabolism of Darunavir can be decreased when combined with Lapatinib.
Levorphanol
Danoprevir
The metabolism of Lapatinib can be decreased when combined with Danoprevir.
Levorphanol
Ribociclib
The metabolism of Lapatinib can be decreased when combined with Ribociclib.
Levorphanol
Stiripentol
The metabolism of Lapatinib can be decreased when combined with Stiripentol.
Levorphanol
Elvitegravir
The metabolism of Lapatinib can be decreased when combined with Elvitegravir.
Levorphanol
Telaprevir
The metabolism of Lapatinib can be decreased when combined with Telaprevir.
Levorphanol
Nilotinib
The metabolism of Lapatinib can be decreased when combined with Nilotinib.
Levorphanol
Ditiocarb
The metabolism of Lapatinib can be decreased when combined with Ditiocarb.
Levorphanol
Posaconazole
The metabolism of Lapatinib can be decreased when combined with Posaconazole.
Levorphanol
Midostaurin
The metabolism of Lapatinib can be decreased when combined with Midostaurin.